Targeting cancer stem cells with antibiotics inducing mitochondrial dysfunction as an alternative anticancer therapy

Karp, Igor and Lyakhovich, Alex (2022) Targeting cancer stem cells with antibiotics inducing mitochondrial dysfunction as an alternative anticancer therapy. Biochemical Pharmacology, 198 . ISSN 0006-2952 (Print) 1873-2968 (Online)

[thumbnail of BCP2022.pdf] PDF
BCP2022.pdf
Restricted to Registered users only

Download (1MB) | Request a copy

Abstract

Traditional cancer treatments based on chemo- and/or radiotherapy effectively kill only differentiated cancer cells, while metastasis and recurrences are caused by surviving cancer resistant cells (CRC) or a special subpopulation of cancer cells known as cancer stem cells (CSC). Both of these cell types compromise anticancer treatment through various mechanisms, including withdrawal of the anticancer drug through ATP-binding cassette transporters, increased expression of DNA repair genes, or transition to a quiescent phenotype. In contrast to many cancers, where energy consumption is due to glycolysis (Warburg effect), the bioenergetics of CSC and CRC is most often related to oxidative phosphorylation, that is, dependent on mitochondrial function. Therefore, compounds that induce mitochondrial dysfunction (MDF), such as some antibiotics, may represent an alternative approach to anticancer therapy. This review summarizes the major recent works on the use of antibiotics to target tumors via CSC and suggests next steps for developing this approach.
Item Type: Article
Divisions: Faculty of Engineering and Natural Sciences
Depositing User: Alex Lyakhovich
Date Deposited: 24 Feb 2022 14:33
Last Modified: 26 Apr 2022 10:28
URI: https://research.sabanciuniv.edu/id/eprint/42755

Actions (login required)

View Item
View Item